Literature DB >> 8854647

Clinical features of interstitial lung diseases.

G I Lim1, K H Lee, S W Jeong, S T Uh, S Y Jin, D H Lee, J S Park, D L Choi, C H Kang, C S Park.   

Abstract

OBJECTIVES: Interstitial lung diseases (ILD) are heterogeneous groups of disorders that involve the interstitium of the lung. Lung biopsy is mandatory in most cases of ILD for diagnosis. In Korea, a few clinical data about ILD were analyzed on the basis of pathologic proof. Thus, we analysed the clinical profiles of patients with ILD who had lung biopsy in a tertiary university hospital.
METHODS: Clinical and pathologic data concerning 100 patients who had open lung biopsy (OLB) and/or transbronchial lung biopsy (TBLB) were prospectively analysed. Two patients were excluded because one patient was proven to have metastatic cancer and the other to have miliary tuberculosis. One patient had two combined diseases: rheumatoid arthritis and pneumoconiosis. Thus, 99 cases were analysed from 98 patients. Demographic characteristics, pulmonary functions and pathologic findings were analysed according to the disease entities of ILD. Pathologic findings were classified only in patients who had OLB. Clinical courses were also analysed during follow-up.
RESULTS: OLB was performed on 68 cases with concomittant TBLB in 18 cases and 30 cases had TBLB only. Mediastinal lymph node biopsy has performed on one case. The most common cause of ILD was IPF (51.5%), which was followed by CVD.PF (15.2%) and HP (9.1%). Average age of 51 cases with idiopathic pulmonary fibrosis (IPF) was 60 +/- 11 years, that of 15 cases with collagen vascular disease associated pulmonary fibrosis (CVD-PF) was 46 +/- 17 years and that of 9 cases with hypersensitivity pneumonitis (HP) was 53 +/- 8.1 years. In IPF, CVD-PF AND HP, male to female ratio was equal. But female was dominant in sarcoidosis and male was dominant in pneumoconiosis. Pulmonary function tests (PFT) in IPF, CVD-PF and HP were restrictive patterns in half of the cases. In pneumoconiosis and sarcoidosis, PFT showed normal pattern. Usual interstitial pneumonia (UIP) was the most common pathologic type in IPF and CVD-PF. The most common cause of CVD-PF was rheumatoid arthritis. The overall mortality rate was 12.1%.
CONCLUSION: We reported that the ILD had a variety of disease entities and pathologic types even in one tertiary referral hospital. We hope that a multi-center study will be performed on the basis of pathologic proof in the future.

Entities:  

Mesh:

Year:  1996        PMID: 8854647      PMCID: PMC4532019          DOI: 10.3904/kjim.1996.11.2.113

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  15 in total

Review 1.  Extracellular matrix injury during lung inflammation.

Authors:  E J Campbell; R M Senior; H G Welgus
Journal:  Chest       Date:  1987-07       Impact factor: 9.410

2.  Diffuse interstitial pulmonary disease from the perspective of the clinician.

Authors:  R A DeRemee
Journal:  Chest       Date:  1987-12       Impact factor: 9.410

3.  Pulmonary hypertension in the interstitial lung diseases.

Authors:  J I Kennedy; J D Fulmer
Journal:  Chest       Date:  1985-05       Impact factor: 9.410

4.  A comparison of bronchiolitis obliterans with organizing pneumonia, usual interstitial pneumonia, and small airways disease.

Authors:  M L Guerry-Force; N L Müller; J L Wright; B Wiggs; C Coppin; P D Pare; J C Hogg
Journal:  Am Rev Respir Dis       Date:  1987-03

Review 5.  State of the art: chronic cor pulmonale.

Authors:  A P Fishman
Journal:  Am Rev Respir Dis       Date:  1976-10

6.  Natural history and treated course of usual and desquamative interstitial pneumonia.

Authors:  C B Carrington; E A Gaensler; R E Coutu; M X FitzGerald; R G Gupta
Journal:  N Engl J Med       Date:  1978-04-13       Impact factor: 91.245

7.  Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlations in 502 patients.

Authors:  E A Gaensler; C B Carrington
Journal:  Ann Thorac Surg       Date:  1980-11       Impact factor: 4.330

8.  Clinical significance of pulmonary function tests. Pulmonary function testing in interstitial pulmonary disease. What does it tell us?

Authors:  B A Keogh; R G Crystal
Journal:  Chest       Date:  1980-12       Impact factor: 9.410

9.  Chronic cor pulmonale in pulmonary sarcoidosis.

Authors:  J P Battesti; R Georges; F Basset; G Saumon
Journal:  Thorax       Date:  1978-02       Impact factor: 9.139

10.  Cryptogenic fibrosing alveolitis and lung cancer.

Authors:  M Turner-Warwick; M Lebowitz; B Burrows; A Johnson
Journal:  Thorax       Date:  1980-07       Impact factor: 9.139

View more
  5 in total

1.  Pulmonary Toxicities of Immunotherapy.

Authors:  Mehmet Altan; Linda Zhong; Vickie R Shannon; Ajay Sheshadri
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Diagnostic Accuracy of Multidetector CT in Detection of Early Interstitial Lung Disease With Its Role in Characterization.

Authors:  Shadab Ahmed; Sachin Khanduri; Mushahid Husain; Ahmad Umar Khan; Anchal Singh; Mridul Rajurkar; Syed Zain Abbas; Nazia Khan
Journal:  Cureus       Date:  2020-05-23

Review 3.  Immune-Related Adverse Events: Pneumonitis.

Authors:  Linda Zhong; Mehmet Altan; Vickie R Shannon; Ajay Sheshadri
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 4.  The epidemiology of interstitial lung disease and its association with lung cancer.

Authors:  G Raghu; F Nyberg; G Morgan
Journal:  Br J Cancer       Date:  2004-08       Impact factor: 7.640

5.  Pleuroparenchymal fibroelastosis in Korean patients: clinico-radiologic-pathologic features and 2-year follow-up.

Authors:  Jae Ha Lee; Eun Jin Chae; Joon Seon Song; Miae Kim; Jin Woo Song
Journal:  Korean J Intern Med       Date:  2020-02-24       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.